Oops.. I was so excited for SEQureDX too, I was really hoping it would have some clinical utility. Considering I’ll be premising my research on the idea of noninvasive prenatal diagnostics. Hopefully the kinks can get worked out, but nevertheless, it really is just a screen, right?
“For those who have been too distracted by swine flu to notice: shares of the biotech company Sequenom have plummeted by 77% after the company announced that the extremely promising initial results for its SEQureDx Down syndrome test – which is designed to detect Down syndrome fetuses using blood samples from pregnant women – were “questionable” and had been mishandled by employees.”